Thyroid-stimulating hormone and free thyroxine fail to predict the severity and clinical course of hyperemesis gravidarum: A prospective cohort study

K. Nijsten*, M.H. Koot, J.A.M. van der Post, J.M.J. Bais, C. Ris-Stalpers, C. Naaktgeboren, H.A. Bremer, D.P. van der Ham, W.M. Heidema, A. Huisjes, G. Kleiverda, S.M. Kuppens, J.O.E.H. van Laar, J. Langenveld, F. van der Made, D. Papatsonis, M.J. Pelinck, P.J. Pernet, L. van Rheenen-Flach, R.J. RijndersH.C.J. Scheepers, S.E. Siegelaar, T. Vogelvang, B. Mol, T.J. Roseboom, I.J. Grooten, R.C. Painter

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1419-1429
Number of pages11
JournalActa Obstetricia et Gynecologica Scandinavica
Issue number8
Publication statusPublished - 1 Aug 2021


  • disease severity marker
  • free thyroxine
  • hyperemesis gravidarum
  • nausea and vomiting in pregnancy
  • thyroid function
  • thyroid&#8208
  • stimulating hormone

Cite this